US BANCORP \DE\ - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$715
-22.6%
9720.0%0.00%
Q2 2023$924
+1.1%
9720.0%0.00%
Q1 2023$914
-5.0%
9720.0%0.00%
Q4 2022$962
-3.8%
9720.0%0.00%
Q3 2022$1,0000.0%9720.0%0.00%
Q2 2022$1,0000.0%972
-6.3%
0.00%
Q1 2022$1,0000.0%1,0370.0%0.00%
Q4 2021$1,000
-50.0%
1,0370.0%0.00%
Q3 2021$2,000
-33.3%
1,037
-7.3%
0.00%
Q2 2021$3,000
-25.0%
1,1190.0%0.00%
Q1 2021$4,0000.0%1,1190.0%0.00%
Q4 2020$4,000
+100.0%
1,119
-8.1%
0.00%
Q3 2020$2,000
-33.3%
1,2170.0%0.00%
Q2 2020$3,000
+200.0%
1,217
-0.4%
0.00%
Q1 2020$1,0000.0%1,2220.0%0.00%
Q4 2019$1,0000.0%1,2220.0%0.00%
Q3 2019$1,000
-66.7%
1,222
-42.0%
0.00%
Q2 2019$3,000
-83.3%
2,107
-66.9%
0.00%
Q1 2019$18,000
-25.0%
6,364
-38.4%
0.00%
Q4 2018$24,000
-41.5%
10,3290.0%0.00%
Q3 2018$41,000
-30.5%
10,329
-13.2%
0.00%
Q2 2018$59,000
-45.4%
11,895
-43.1%
0.00%
Q1 2018$108,000
-42.9%
20,896
-43.7%
0.00%
-100.0%
Q4 2017$189,000
-51.5%
37,111
-46.6%
0.00%0.0%
Q3 2017$390,000
-43.5%
69,472
-39.6%
0.00%
-50.0%
Q2 2017$690,000
-67.1%
114,980
-67.4%
0.00%
-71.4%
Q1 2017$2,099,000
-11.2%
352,184
+3.1%
0.01%
-22.2%
Q4 2016$2,365,000
-47.5%
341,726
+0.2%
0.01%
-47.1%
Q3 2016$4,507,000
+13.5%
340,875
-2.6%
0.02%
+13.3%
Q2 2016$3,970,000
+4.7%
350,070
+7.6%
0.02%0.0%
Q1 2016$3,792,000
+35.0%
325,213
+36.2%
0.02%
+36.4%
Q4 2015$2,808,000
+108.8%
238,825
+103.1%
0.01%
+83.3%
Q3 2015$1,345,000
+4.4%
117,611
+64.9%
0.01%
+20.0%
Q2 2015$1,288,000
+26.4%
71,334
+34.7%
0.01%
+25.0%
Q1 2015$1,019,000
+28.3%
52,966
+16.7%
0.00%
+33.3%
Q4 2014$794,000
-25.9%
45,370
-22.6%
0.00%
-25.0%
Q3 2014$1,072,000
-45.3%
58,610
-31.1%
0.00%
-50.0%
Q2 2014$1,960,000
-1.4%
85,077
+3.8%
0.01%0.0%
Q1 2014$1,987,000
+36.6%
81,983
+41.7%
0.01%
+33.3%
Q4 2013$1,455,000
+80.3%
57,863
+56.0%
0.01%
+50.0%
Q3 2013$807,000
+145.3%
37,082
+90.3%
0.00%
+100.0%
Q2 2013$329,00019,4860.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q1 2023
NameSharesValueWeighting ↓
ACK Asset Management 657,100$11,072,0004.49%
GOLDMAN CAPITAL MANAGEMENT INC 343,000$5,780,0003.30%
Lyon Street Capital, LLC 368,858$6,215,257,0003.08%
JAY JEFFREY R 163,140$2,749,0002.17%
Adirondack Research & Management Inc. 161,507$2,721,0002.03%
Park West Asset Management LLC 448,415$7,556,0000.89%
Benchmark Capital Advisors 51,600$869,0000.67%
SHEPHERD KAPLAN KROCHUK, LLC 166,034$2,797,0000.55%
HEARTLAND ADVISORS INC 1,569,699$26,449,0000.49%
WOODMONT INVESTMENT COUNSEL LLC 86,682$1,461,0000.49%
View complete list of TRINITY BIOTECH PLC shareholders